Every previous GLP-1 medication, including semaglutide and tirzepatide, shows weight loss plateaus by 60 to 72 weeks
Is one better than the other
They can help to protect the liver from damage, promote the regeneration of liver cells, and improve liver function
The findings, which have yet to be published, showed that Tirzepatide reduced participants risk of heart failure outcomes (hospitalization, death, and the need to increase medication dosage) by 38 percent compared with those taking placebo
It is educational and not medical advice
Evidence-based strategies focus primarily on preventing and managing gastrointestinal symptoms, maintaining hydration, and supporting patients through the adaptation period